These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24908667)

  • 1. Bent bone dysplasia syndrome reveals nucleolar activity for FGFR2 in ribosomal DNA transcription.
    Neben CL; Idoni B; Salva JE; Tuzon CT; Rice JC; Krakow D; Merrill AE
    Hum Mol Genet; 2014 Nov; 23(21):5659-71. PubMed ID: 24908667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGFR2 mutations in bent bone dysplasia syndrome activate nucleolar stress and perturb cell fate determination.
    Neben CL; Tuzon CT; Mao X; Lay FD; Merrill AE
    Hum Mol Genet; 2017 Sep; 26(17):3253-3270. PubMed ID: 28595297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1/2 and protein kinase C signaling.
    Miraoui H; Oudina K; Petite H; Tanimoto Y; Moriyama K; Marie PJ
    J Biol Chem; 2009 Feb; 284(8):4897-904. PubMed ID: 19117954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for fibroblast growth factor receptor-2 in the altered osteoblast phenotype induced by Twist haploinsufficiency in the Saethre-Chotzen syndrome.
    Guenou H; Kaabeche K; Mée SL; Marie PJ
    Hum Mol Genet; 2005 Jun; 14(11):1429-39. PubMed ID: 15829502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bent bone dysplasia-FGFR2 type, a distinct skeletal disorder, has deficient canonical FGF signaling.
    Merrill AE; Sarukhanov A; Krejci P; Idoni B; Camacho N; Estrada KD; Lyons KM; Deixler H; Robinson H; Chitayat D; Curry CJ; Lachman RS; Wilcox WR; Krakow D
    Am J Hum Genet; 2012 Mar; 90(3):550-7. PubMed ID: 22387015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of a novel FGFR2 mutation, E731K, in craniosynostosis.
    Park J; Park OJ; Yoon WJ; Kim HJ; Choi KY; Cho TJ; Ryoo HM
    J Cell Biochem; 2012 Feb; 113(2):457-64. PubMed ID: 21928350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of nanogel-based delivery of soluble FGFR2 with S252W mutation on craniosynostosis.
    Yokota M; Kobayashi Y; Morita J; Suzuki H; Hashimoto Y; Sasaki Y; Akiyoshi K; Moriyama K
    PLoS One; 2014; 9(7):e101693. PubMed ID: 25003957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
    Ang BU; Spivak RM; Nah HD; Kirschner RE
    J Craniofac Surg; 2010 Mar; 21(2):462-7. PubMed ID: 20489451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apert syndrome mutant FGFR2 and its soluble form reciprocally alter osteogenesis of primary calvarial osteoblasts.
    Suzuki H; Suda N; Shiga M; Kobayashi Y; Nakamura M; Iseki S; Moriyama K
    J Cell Physiol; 2012 Sep; 227(9):3267-77. PubMed ID: 22105374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
    Mansukhani A; Bellosta P; Sahni M; Basilico C
    J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome.
    Tanimoto Y; Yokozeki M; Hiura K; Matsumoto K; Nakanishi H; Matsumoto T; Marie PJ; Moriyama K
    J Biol Chem; 2004 Oct; 279(44):45926-34. PubMed ID: 15310757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolyl isomerase Pin1-mediated conformational change and subnuclear focal accumulation of Runx2 are crucial for fibroblast growth factor 2 (FGF2)-induced osteoblast differentiation.
    Yoon WJ; Cho YD; Kim WJ; Bae HS; Islam R; Woo KM; Baek JH; Bae SC; Ryoo HM
    J Biol Chem; 2014 Mar; 289(13):8828-38. PubMed ID: 24509851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF2 effects in periosteal fibroblasts bearing the FGFR2 receptor Pro253 Arg mutation.
    Lilli C; Bellucci C; Baroni T; Aisa C; Carinci P; Scapoli L; Carinci F; Pezzetti F; Lumare E; Stabellini G; Bodo M
    Cytokine; 2007 Apr; 38(1):22-31. PubMed ID: 17537644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of FGFR Signaling on Cell Proliferation and Differentiation of Apert Dental Cells.
    Lu C; Huguley S; Cui C; Cabaniss LB; Waite PD; Sarver DM; Mamaeva OA; MacDougall M
    Cells Tissues Organs; 2016; 201(1):26-37. PubMed ID: 26613250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel molecular pathways elicited by mutant FGFR2 may account for brain abnormalities in Apert syndrome.
    Yeh E; Fanganiello RD; Sunaga DY; Zhou X; Holmes G; Rocha KM; Alonso N; Matushita H; Wang Y; Jabs EW; Passos-Bueno MR
    PLoS One; 2013; 8(4):e60439. PubMed ID: 23593218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation.
    Baroni T; Carinci P; Lilli C; Bellucci C; Aisa MC; Scapoli L; Volinia S; Carinci F; Pezzetti F; Calvitti M; Farina A; Conte C; Bodo M
    J Cell Physiol; 2005 Feb; 202(2):524-35. PubMed ID: 15389579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2.
    Young DW; Hassan MQ; Pratap J; Galindo M; Zaidi SK; Lee SH; Yang X; Xie R; Javed A; Underwood JM; Furcinitti P; Imbalzano AN; Penman S; Nickerson JA; Montecino MA; Lian JB; Stein JL; van Wijnen AJ; Stein GS
    Nature; 2007 Jan; 445(7126):442-6. PubMed ID: 17251981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis.
    Yin L; Du X; Li C; Xu X; Chen Z; Su N; Zhao L; Qi H; Li F; Xue J; Yang J; Jin M; Deng C; Chen L
    Bone; 2008 Apr; 42(4):631-43. PubMed ID: 18242159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Ser252Trp mutation in fibroblast growth factor receptor 2 (FGFR2) mimicking human Apert syndrome reveals an essential role for FGF signaling in the regulation of endochondral bone formation.
    Chen P; Zhang L; Weng T; Zhang S; Sun S; Chang M; Li Y; Zhang B; Zhang L
    PLoS One; 2014; 9(1):e87311. PubMed ID: 24489893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of FGFR2-IIIC signaling via FGF-2 ligand for advancing GCT stromal cell differentiation.
    Singh S; Singh M; Mak IW; Turcotte R; Ghert M
    PLoS One; 2012; 7(10):e46769. PubMed ID: 23071632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.